Result Summary for APVF3032
| Protocol ID: | APVF3032 |
| Clinical Study ID: | APVF3032 |
| Official Title: | Efficacy and pharmacologic evaluation at week 4 of fosamprenavir/ritonavir BID in HIV, pretreated patients switching from amprenavir/ritonavir with controlled plasma viremia. |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | fosamprenavir |
| Trade/Product Name: | lexiva;lexiva |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
